Skip to main content
. 2017 Nov 14;71(6):498–503. doi: 10.1136/jclinpath-2017-204714

Table 1.

Primers used for drug-resistant gene amplification

Genes Primers (sequences 5'→3') Product size (bp)
rpoB F (5′-ACGGTCGGCGAGCTGATCC-3′)
R (5′-CAGACCGATGTTGGGCCCCT-3′)
351
katG F (5′-GACATTCGCGAGACGTTTCGG-3′)
R (5′-GCTCTTAAGGCTGGCAATCTCG-3′)
469
inhA F (5′-CTATATCTCCGGTGCGGTCA-3′)
R (5′-CTTGGCCATCGAAGCATAC-3′)
469
rpsL F (5′-AGGTCACGGCGTACATTCC-3′)
R(5′-GCCCTTCTCCTTCTTAGCG-3′)
188
embB F (5′-TGATATTCGGCTTCCTGCTC-3′)
R (5′-ACCGCTCGATCAGCACATAG-3′)
417

embB, EMB mutant gene; katG and inhA, INH mutant gene; rpoB, RFP mutant gene; rpsL, SM mutant gene.